BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33128074)

  • 1. Methotrexate osteopathy: five cases and systematic literature review.
    Robin F; Cadiou S; Albert JD; Bart G; Coiffier G; Guggenbuhl P
    Osteoporos Int; 2021 Feb; 32(2):225-232. PubMed ID: 33128074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review.
    Ruffer N; Krusche M; Beil FT; Amling M; Kötter I; Rolvien T
    Semin Arthritis Rheum; 2022 Feb; 52():151952. PubMed ID: 35038641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate osteopathy, does it exist?
    Maenaut K; Westhovens R; Dequeker J
    J Rheumatol; 1996 Dec; 23(12):2156-9. PubMed ID: 8970056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis.
    Zonneveld IM; Bakker WK; Dijkstra PF; Bos JD; van Soesbergen RM; Dinant HJ
    Arch Dermatol; 1996 Feb; 132(2):184-7. PubMed ID: 8629827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
    Rolvien T; Jandl NM; Stürznickel J; Beil FT; Kötter I; Oheim R; Lohse AW; Barvencik F; Amling M
    Calcif Tissue Int; 2021 Feb; 108(2):219-230. PubMed ID: 33064170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low dose methotrexate on bone density.
    Cranney AB; McKendry RJ; Wells GA; Ooi DS; Kanigsberg ND; Kraag GR; Smith CD
    J Rheumatol; 2001 Nov; 28(11):2395-9. PubMed ID: 11708409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
    J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study.
    di Munno O; Mazzantini M; Sinigaglia L; Bianchi G; Minisola G; Muratore M; la Corte R; di Matteo L; Canesi B; Caminiti M; Broggini M; Adami S
    J Rheumatol; 2004 Jul; 31(7):1305-9. PubMed ID: 15229948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three patients with a fracture during methotrexate use, possibly due to methotrexate osteopathy].
    van der Bijl AE; Zijlstra TR; Engelage AH; Posthuma BJ; van Veen GJ
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2357-60. PubMed ID: 19024069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density.
    Minaur NJ; Kounali D; Vedi S; Compston JE; Beresford JN; Bhalla AK
    Rheumatology (Oxford); 2002 Jul; 41(7):741-9. PubMed ID: 12096222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in rheumatoid arthritis.
    Dequeker J; Maenaut K; Verwilghen J; Westhovens R
    Clin Exp Rheumatol; 1995; 13 Suppl 12():S21-6. PubMed ID: 8846540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate osteopathy demonstrated by Technetium-99m HDP bone scintigraphy.
    Stevens H; Jacobs JW; Van Rijk PP; De Klerk JM
    Clin Nucl Med; 2001 May; 26(5):389-91. PubMed ID: 11317015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of low dose methotrexate treatment on bone mineral density in patients with rheumatoid arthritis].
    Kita K; Sierakowski S
    Pol Merkur Lekarski; 2002 Feb; 12(68):122-5. PubMed ID: 11995248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy.
    Rolvien T; Creutzfeldt AM; Lohse AW; Amling M
    Lupus; 2019 May; 28(6):790-793. PubMed ID: 30947618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced osteopathy in rheumatology].
    Fiehn C; Bauhammer J
    Z Rheumatol; 2022 Apr; 81(3):189-197. PubMed ID: 35006380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage.
    Minaur NJ; Jefferiss C; Bhalla AK; Beresford JN
    Rheumatology (Oxford); 2002 Jul; 41(7):735-40. PubMed ID: 12096221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
    Kremer JM; Alarcón GS; Weinblatt ME; Kaymakcian MV; Macaluso M; Cannon GW; Palmer WR; Sundy JS; St Clair EW; Alexander RW; Smith GJ; Axiotis CA
    Arthritis Rheum; 1997 Oct; 40(10):1829-37. PubMed ID: 9336418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis and osteoporosis.
    Westhovens R; Dequeker J
    Z Rheumatol; 2000; 59 Suppl 1():33-8. PubMed ID: 10769433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.